QuickView for slc18a2 protein, human (compound)

1. Valbenazine for the treatment of tardive dyskinesia.
2. Valbenazine for the treatment of tardive dyskinesia.
3. Efficient Trial Design - FDA Approval of Valbenazine for Tardive Dyskinesia.
4. Fuzzy Decision Making Approach to Identify Optimum Enzyme Targets and Drug Dosage for Remedying Pres…
5. Management Impact of Imaging Brain Vesicular Monoamine Transporter Type 2 in Clinically Uncertain Pa…

There were no clinical trials for slc18a2 protein, human